Data Insights

IMA-402 by Immatics for Uveal Melanoma: Likelihood of Approval

IMA-402 is under clinical development by Immatics and currently in Phase II for Uveal Melanoma. According to GlobalData, Phase II...

Likelihood of Approval and Phase Transition Success Rate Model - IMA-402 in Uveal Melanoma

Data Insights

IMA-402 by Immatics for Synovial Sarcoma: Likelihood of Approval

IMA-402 is under clinical development by Immatics and currently in Phase II for Synovial Sarcoma. According to GlobalData, Phase II...

Likelihood of Approval and Phase Transition Success Rate Model - IMA-402 in Synovial Sarcoma

Data Insights

IMA-402 by Immatics for Uterine Cancer: Likelihood of Approval

IMA-402 is under clinical development by Immatics and currently in Phase II for Uterine Cancer. According to GlobalData, Phase II...

Likelihood of Approval and Phase Transition Success Rate Model - IMA-402 in Uterine Cancer

Data Insights

IMA-402 by Immatics for Solid Tumor: Likelihood of Approval

IMA-402 is under clinical development by Immatics and currently in Phase II for Solid Tumor. According to GlobalData, Phase II...

Likelihood of Approval and Phase Transition Success Rate Model - IMA-402 in Solid Tumor

Data Insights

IMA-402 by Immatics for Ovarian Cancer: Likelihood of Approval

IMA-402 is under clinical development by Immatics and currently in Phase II for Ovarian Cancer. According to GlobalData, Phase II...

Likelihood of Approval and Phase Transition Success Rate Model - IMA-402 in Ovarian Cancer

Data Insights

IMA-402 by Immatics for Lung Cancer: Likelihood of Approval

IMA-402 is under clinical development by Immatics and currently in Phase II for Lung Cancer. According to GlobalData, Phase II...

Likelihood of Approval and Phase Transition Success Rate Model - IMA-402 in Lung Cancer